Rocket to merge with Inotek to bag Nasdaq listing, plots gene therapy trials – FierceBiotech
FierceBiotech |
Rocket to merge with Inotek to bag Nasdaq listing, plots gene therapy trials
FierceBiotech Rocket Pharmaceuticals has landed a Nasdaq listing through a reverse merger. The deal will see the low-profile gene therapy startup merge with floundering Inotek Pharmaceuticals before embarking on a clutch of clinical trials. Shareholders in Rocket … Rocket Pharma and Inotek plan reverse merge |
